| Literature DB >> 26873846 |
Lucia De Monte1, Sonja Wörmann2, Emanuela Brunetto3, Silvia Heltai1, Gilda Magliacane4, Michele Reni5, Anna Maria Paganoni6, Helios Recalde7, Anna Mondino8, Massimo Falconi9, Francesca Aleotti10, Gianpaolo Balzano10, Hana Algül2, Claudio Doglioni11, Maria Pia Protti12.
Abstract
In pancreatic ductal adenocarcinomas (PDAC), lymphoid infiltrates, comprised mainly of Th2 cells, predict a poor survival outcome in patients. IL4 signaling has been suggested to stabilize the Th2 phenotype in this setting, but the cellular source of IL4 in PDAC is unclear. Here, we show that basophils expressing IL4 are enriched in tumor-draining lymph nodes (TDLN) of PDAC patients. Basophils present in TDLNs correlated significantly with the Th2/Th1 cell ratio in tumors, where they served as an independent prognostic biomarker of patient survival after surgery. Investigations in mouse models of pancreatic cancer confirmed a functional role for basophils during tumor progression. The recruitment of basophils into TDLN relied partly upon the release of chemokine CCL7/MCP3 by "alternatively activated" monocytes, whereas basophil activation was induced by T-cell-derived IL3. Our results show how basophils recruited and activated in TDLNs under the influence of the tumor microenvironment regulate tumor-promoting Th2 inflammation in PDAC, helping in illuminating a key element of the immune milieu of pancreatic cancer. Cancer Res; 76(7); 1792-803. ©2016 AACR. ©2016 American Association for Cancer Research.Entities:
Mesh:
Year: 2016 PMID: 26873846 DOI: 10.1158/0008-5472.CAN-15-1801-T
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701